The China Business Law Journal has honored Goodwin with three China Business Law Awards for 2021. The annual awards noted the firm’s accomplishments in the following categories:
- Private Equity & Venture Capital
- Healthcare, Pharma & Life Sciences
- Consumer & Retail
The China Business Law Journal praised Goodwin’s Life Sciences practice for their work on “some significant deals, from financing, M&A, and capital markets, to collaborations and licensing.” They highlighted the Goodwin teams, led by Wenseng “Wendy” Pan, which represented Apollomics in its $124.2 million Series C financing led by Ping An Capital, and Impact Therapeutics in forming a joint venture with Junshi Biosciences in China to develop and commercialize a PARP inhibitor for the treatment of cancers in Greater China.
These awards build on the success of the firm’s Hong Kong-based Asia practice. Among their recent high-profile deals, a Private Equity and Life Sciences team led by Yash Rana, Abhishek Krishnan and Kingsley Taft advised Hillhouse Capital on its investment in Everest Medicines as a co-lead investor in Everest Medicine’s Series C financing of $310 million. Another Private Equity and Life Sciences team led by Yash Rana, Chi Pan and Kingsley Taft advised Hillhouse on leading a consortium of institutional investors that entered into definitive subscription agreements with I-Mab (Nasdaq: IMAB) to raise $418 million through a private placement. Additionally, a cross-border team led by Douglas Freeman, Victor Chen and Daniel Lindsey in Hong Kong and Carl Bradshaw, Simon Thomas and Gretchen Scott in London advised LionRock Capital on its acquisition of a majority stake in leading UK shoe manufacturer and retailer Clarks.
Goodwin was named the 2021 M&A Firm of the Year for Medium-Sized Deals Under $500 Million by the Asia Legal Awards, and recognized by the India Law Journal for Deals of the Year in Private Equity & Venture Capital. Goodwin was also highly ranked across practices by Chambers Asia-Pacific 2021, Chambers Global 2021 and The Legal 500 Asia-Pacific 2021.
The China Business Law Awards honor the very best domestic and international law firms serving the Chinese marketplace. The results are based on an exhaustive research process that takes into account landmark deals, notable cases, and feedback from corporate counsel, legal professionals, and clients around the world.Please visit China Business Law Journal’s website to view the full list of winners.